CM
EPZM

Caption Management’s Epizyme, Inc EPZM Stock Holding History

Caption Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-44,445
Closed -$228K – 2072
2021
Q3 		$228K Sell
44,445
-55,093
-55% -$335K ﹤0.01% 1327
2021
Q2 		$827K Buy
99,538
+61,258
+160% +$516K 0.01% 943
2021
Q1 		$334K Sell
38,280
-4,341
-10% -$44.9K 0.01% 869
2020
Q4 		$462K Buy
+42,621
New +$526K 0.01% 750
2020
Q3 		– Sell
-160,010
Closed -$2.57M – 1357
2020
Q2 		$2.57M Buy
160,010
+92,510
+137% +$1.61M 0.09% 320
2020
Q1 		$1.05M Buy
+67,500
New +$1.45M 0.06% 391
2019
Q3 		– Sell
-6,000
Closed -$75K – 955
2019
Q2 		$75K Buy
+6,000
New +$77.2K ﹤0.01% 620

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Caption Management's EPZM Position: Q4 2021 in Review

Caption Management sold out of Epizyme, Inc (EPZM) in Q4 2021, closing a stake of 44,445 shares — an estimated $228K sold.

Caption Management first reported a position in EPZM in Q2 2019 and held it in 7 quarters. The position peaked at $2.57M in Q2 2020. 132 funds tracked by Wall St. Rank hold EPZM as of Q4 2021.

  • Caption Management reported no remaining Epizyme, Inc position as of Q4 2021 after selling out during the quarter.
  • Caption Management sold 44,445 Epizyme, Inc shares in Q4 2021, an estimated $228K.
  • Caption Management first reported a position in Epizyme, Inc in Q2 2019 and held it in 7 quarters.
  • Caption Management's Epizyme, Inc position peaked at $2.57M in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.